| Version |
1.0 |
| Creation Date |
2009-03-06 18:57:56 |
| Update Date |
2010-03-18 21:52:15 |
| Accession Number |
T3D0019 |
| Name |
Phosphorus |
| Compound Type |
- Inorganic Compound
- Non-Metal
|
| Description |
White phosphorus is an allotrope of elemental phosphorus. It does not occur naturally, but is manufactured from phosphate rocks. Since it is a smoke-producing and incendiary agent, it has many military applications, especially in smokescreens, bombs, artillery, and mortars. It is also used by industry to produce phosphoric acid and other chemicals for use in fertilizers, food additives, and cleaning compounds. (R156, R157) |
| Synonyms |
- Hittorf's phosphorus
- Oligostim Phosphore - Tab 6dh
- Pekana - phosphorus
- Phosphate-novartis
- Phosphorous
- Phosphorus Pwr 6x
- Phosphorus Tri-Iodatus 3ch - 30ch
- Phosphorus flavus
- Phosphorus homaccord
- Phosphorus-30
- Red phosphorus
- Tonimine liq
- White phosphorus
|
| Chemical IUPAC Name |
phosphanylidyne |
| Chemical Formula |
P |
| Chemical Structure |
 |
| CAS Registry Number |
7723-14-0 |
| InChI Identifier |
InChI=1S/P |
| InChI Key |
InChIKey=OAICVXFJPJFONN-UHFFFAOYSA-N |
| PubChem Compound ID |
5462309  |
| KEGG ID |
C06262  |
| UniProt ID |
Not Available |
| OMIM ID |
168470
602079
606656  |
| ChEBI ID |
28659  |
| BioCyc ID |
Not Available |
| SuperToxic ID |
Not Available |
| CTD ID |
D010758  |
| Stitch ID |
Phosphorus, white  |
| DrugBank ID |
Not Available |
| PDB ID |
Not Available |
| ACToR ID |
6567 |
| Wikipedia Link |
http://en.wikipedia.org/wiki/Phosphorus  |
| Monoisotopic Mass |
30.973762 |
| MOL File |
Show |
| PDB File |
Show |
| SDF File |
Show |
| SMILES |
[P] |
| Appearance |
White solid that becomes yellow when exposed to light. |
| Melting Point |
44.1 °C |
| Solubility |
0.0033 mg/mL at 15 oC [KIRK-OTHMER; on-line (2005)] |
| Predicted LogP |
0.3 |
| Route of Exposure |
Oral (R516) ; inhalation (R516) ; dermal (R516) |
| Mechanism of Action |
Exposure to white phosphorus has been shown to damage the rough endoplasmic reticulum and cause a disaggregation of polyribosomes. This damage results in impairment of protein synthesis, in particular, a decrease in the synthesis of the apolipoprotein portion of very low density lipoproteins (VLDL), which are required for the transport of triglycerides. This causes an accumulation of triglycerides in the liver, resulting in steatosis and fibrosis. White phosphorus also damages the mitochondia, impairing a cell’s ability to produce ATP and resulting in necrosis. The mitochondrial damage may also inhibit fatty acid oxidation, which could result in an accumulation of fat in the organs. Excess phosphorus decreases the absorption of intercellular calcified cartilage matrix by osteoclasts in the metaphyseal region of growing bones, decreasing the rate of growth of long bones. It may also enhance deposition of calcium by activating sodium-dependent phosphate transporter 1, bone morphogenic proteins 2 and 4, leptin, endogenous 1,25 dihydroxy vitamin D, vascular calcification activating factor, and measures of oxidative stress. (R156, R208) |
| Metabolism |
Phosphorus may be absorbed from ingestion, inhalation, or skin contact and is widely distributed throughout the body, especially in the liver, kidney, blood, spleen, and brain. Since white phosphorus is highly reactive in the presence of oxygen, it is likely rapidly converted to its oxidation products prior to absorption into the body. Little is known about the metabolism of white phosphorus in the body, although the oxo acids of phophorus are known to be found in the bloodstream. Phosphorus in the body is regulated by parathyroid hormone, calcitriol, and fibroblast growth factor 23. (R156, R207) |
| Toxicity Values |
Not Available |
| Lethal Dose |
50 mg for an adult human. (R270) |
| Carcinogenicity (IARC Classification) |
Not Available |
| Uses/Sources |
White phosphorus is used in many military applications, especially in smokescreens, bombs, artillery, and mortars. It is also used by industry to produce phosphoric acid and other chemicals for use in fertilizers, food additives, and cleaning compounds. (R156) |
| Minimum Risk Level |
Acute Inhalation: 0.02 mg/m3 (R260)
Intermediate Oral: 0.0002 mg/kg/day (R260) |
| Health Effects |
Exposure to white phosphorus may cause liver, heart, or kidney damage. It can also result in death. Breathing white phosphorus for long periods may cause a condition known as "phossy jaw", which involves poor wound healing of the mouth and breakdown of the jaw bone. Anemia and leukopenia in people chronically exposed to airborne white phosphorus. (R156) |
| Symptoms |
Breathing white phosphorus for short periods may cause coughing and irritation of the throat and lungs. Eating or drinking small amounts of white phosphorus may cause stomach cramps, or drowsiness. (R156) |
| Treatment |
Ingestion of white phosphorus can be treated with gastric lavage. Otherwise, treatment is mainly symptomatic. (R156) |
| General References |
- R156 - ATSDR - Agency for Toxic Substances and Disease Registry (1997). Toxicological profile for white phosphorus. U.S. Public Health Service in collaboration with U.S. Environmental Protection Agency (EPA).
- R270 - HSDB: Hazardous Substances Data Bank. National Library of Medicine (2001).
- R208 - McCullough PA, Chinnaiyan KM, Agrawal V, Danielewicz E, Abela GS: Amplification of atherosclerotic calcification and Monckeberg's sclerosis: a spectrum of the same disease process. Adv Chronic Kidney Dis. 2008 Oct;15(4):396-412. [PubMed
]
- R260 - ATSDR - Agency for Toxic Substances and Disease Registry (2001). Minimal Risk Levels (MRLs) for Hazardous Substances. U.S. Public Health Service in collaboration with U.S. Environmental Protection Agency (EPA).
- R207 - Doyle ME, Jan de Beur SM: The skeleton: endocrine regulator of phosphate homeostasis. Curr Osteoporos Rep. 2008 Dec;6(4):134-41. [PubMed
]
- R157 - Wikipedia. Allotropes of phosphorus. Last Updated 30 March 2009.
|
| Targets |
- Leptin
- Sodium-dependent phosphate transporter 1
|
|
Target 1
[top]
|
| Target 1 ID |
210 |
| Target 1 Name |
Leptin |
| Target 1 Mechanism of Action |
Phosphorus may enhance deposition of calcium by activating leptin. (R207) |
| Target 1 Description |
May function as part of a signaling pathway that acts to regulate the size of the body fat depot. An increase in the level of LEP may act directly or indirectly on the CNS to inhibit food intake and/or regulate energy expenditure as part of a homeostatic mechanism to maintain constancy of the adipose mass |
| Target 1 Synonyms |
- Obesity factor; Obese protein
|
| Target 1 Gene Name |
LEP |
| Target 1 Protein Sequence |
>Leptin
MHWGTLCGFLWLWPYLFYVQAVPIQKVQDDTKTLIKTIVTRINDISHTQSVSSKQKVTGL
DFIPGLHPILTLSKMDQTLAVYQQILTSMPSRNVIQISNDLENLRDLLHVLAFSKSCHLP
WASGLETLDSLGGVLEASGYSTEVVALSRLQGSLQDMLWQLDLSPGC
|
| Target 1 Number of Residues |
167 |
| Target 1 Molecular Weight |
18640.4 |
| Target 1 Theoretical pI |
6.34 |
| Target 1 GO Classification |
|
Function
|
signal transducer activity
receptor binding
hormone activity |
|
Process
|
cellular process
cell communication
signal transduction |
|
Component
|
| extracellular region |
|
| Target 1 General Function |
Involved in hormone activity |
| Target 1 Pathways |
Not Available |
| Target 1 Reactions |
Not Available |
| Target 1 Signals |
|
| Target 1 Transmembrane Regions |
|
| Target 1 Essentiality |
Non Essential |
| Target 1 Domain Function |
PF02024:Leptin |
| Target 1 GenBank ID Protein |
Not Available |
| Target 1 UniProtKB ID |
P41159  |
| Target 1 Cellular Location |
Secreted |
| Target 1 Gene Sequence |
Not Available |
| Target 1 GenBank Gene ID |
Not Available |
| Target 1 GeneCard ID |
LEP  |
| Target 1 GenAtlas ID |
LEP  |
| Target 1 HGNC ID |
HGNC:6553  |
| Target 1 Chromosome Location |
Not Available |
| Target 1 Locus |
7q31.3 |
| Target 1 SNPs |
SNPJam Report  |
| Target 1 Toxin References |
- R207 - Doyle ME, Jan de Beur SM: The skeleton: endocrine regulator of phosphate homeostasis. Curr Osteoporos Rep. 2008 Dec;6(4):134-41. [PubMed
]
|
| Target 1 General References |
7984236; 7789654; 8626726; 7499240; 8621021; 15489334 |
|
Target 2
[top]
|
| Target 2 ID |
293 |
| Target 2 Name |
Sodium-dependent phosphate transporter 1 |
| Target 2 Mechanism of Action |
Phosphorus may enhance deposition of calcium by activating sodium-dependent phosphate transporter 1. (R207) |
| Target 2 Description |
Sodium-phosphate symporter which plays a fundamental housekeeping role in phosphate transport, such as absorbing phosphate from interstitial fluid for normal cellular functions such as cellular metabolism, signal transduction, and nucleic acid and lipid synthesis. May play a role in extracellular matrix and cartilage calcification as well as in vascular calcification. May function as a retroviral receptor as it confers human cells susceptibility to infection to Gibbon Ape Leukemia Virus (GaLV), Simian sarcoma-associated virus (SSAV) and Feline leukemia virus subgroup B (FeLV-B) as well as 10A1 murine leukemia virus (10A1 MLV) |
| Target 2 Synonyms |
- Solute carrier family 20 member 1; Phosphate transporter 1; PiT-1; Gibbon ape leukemia virus receptor 1; GLVR-1; Leukemia virus receptor 1 homolog
|
| Target 2 Gene Name |
SLC20A1 |
| Target 2 Protein Sequence |
>Sodium-dependent phosphate transporter 1
MATLITSTTAATAASGPLVDYLWMLILGFIIAFVLAFSVGANDVANSFGTAVGSGVVTLK
QACILASIFETVGSVLLGAKVSETIRKGLIDVEMYNSTQGLLMAGSVSAMFGSAVWQLVA
SFLKLPISGTHCIVGATIGFSLVAKGQEGVKWSELIKIVMSWFVSPLLSGIMSGILFFLV
RAFILHKADPVPNGLRALPVFYACTVGINLFSIMYTGAPLLGFDKLPLWGTILISVGCAV
FCALIVWFFVCPRMKRKIEREIKCSPSESPLMEKKNSLKEDHEETKLSVGDIENKHPVSE
VGPATVPLQAVVEERTVSFKLGDLEEAPERERLPSVDLKEETSIDSTVNGAVQLPNGNLV
QFSQAVSNQINSSGHYQYHTVHKDSGLYKELLHKLHLAKVGDCMGDSGDKPLRRNNSYTS
YTMAICGMPLDSFRAKEGEQKGEEMEKLTWPNADSKKRIRMDSYTSYCNAVSDLHSASEI
DMSVKAEMGLGDRKGSNGSLEEWYDQDKPEVSLLFQFLQILTACFGSFAHGGNDVSNAIG
PLVALYLVYDTGDVSSKVATPIWLLLYGGVGICVGLWVWGRRVIQTMGKDLTPITPSSGF
SIELASALTVVIASNIGLPISTTHCKVGSVVSVGWLRSKKAVDWRLFRNIFMAWFVTVPI
SGVISAAIMAIFRYVILRM
|
| Target 2 Number of Residues |
679 |
| Target 2 Molecular Weight |
73699.0 |
| Target 2 Theoretical pI |
7.08 |
| Target 2 GO Classification |
|
Function
|
transporter activity
ion transporter activity
anion transporter activity
inorganic anion transporter activity
phosphate transporter activity
inorganic phosphate transporter activity |
|
Process
|
physiological process
cellular physiological process
transport
ion transport
anion transport
inorganic anion transport
phosphate transport |
|
Component
|
cell
membrane |
|
| Target 2 General Function |
Inorganic ion transport and metabolism |
| Target 2 Pathways |
Not Available |
| Target 2 Reactions |
Not Available |
| Target 2 Signals |
|
| Target 2 Transmembrane Regions |
- 21-41
- 62-82
- 100-120
- 158-178
- 203-223
- 230-250
- 511-531
- 558-578
- 600-620
- 650-670
|
| Target 2 Essentiality |
Non Essential |
| Target 2 Domain Function |
PF01384:PHO4 |
| Target 2 GenBank ID Protein |
Not Available |
| Target 2 UniProtKB ID |
Q8WUM9  |
| Target 2 Cellular Location |
Membrane |
| Target 2 Gene Sequence |
>2040 bp
ATGGCAACGCTGATTACCAGTACTACAGCTGCTACCGCCGCTTCTGGTCCTTTGGTGGAC
TACCTATGGATGCTCATCCTGGGCTTCATTATTGCATTTGTCTTGGCATTCTCCGTGGGA
GCCAATGATGTAGCAAATTCTTTTGGTACAGCTGTGGGCTCAGGTGTAGTGACCCTGAAG
CAAGCCTGCATCCTAGCTAGCATCTTTGAAACAGTGGGCTCTGTCTTACTGGGGGCCAAA
GTGAGCGAAACCATCCGGAAGGGCTTGATTGACGTGGAGATGTACAACTCGACTCAAGGG
CTACTGATGGCCGGCTCAGTCAGTGCTATGTTTGGTTCTGCTGTGTGGCAACTCGTGGCT
TCGTTTTTGAAGCTCCCTATTTCTGGAACCCATTGTATTGTTGGTGCAACTATTGGTTTC
TCCCTCGTGGCAAAGGGGCAGGAGGGTGTCAAGTGGTCTGAACTGATAAAAATTGTGATG
TCTTGGTTCGTGTCCCCACTGCTTTCTGGAATTATGTCTGGAATTTTATTCTTCCTGGTT
CGTGCATTCATCCTCCATAAGGCAGATCCAGTTCCTAATGGTTTGCGAGCTTTGCCAGTT
TTCTATGCCTGCACAGTTGGAATAAACCTCTTTTCCATCATGTATACTGGAGCACCGTTG
CTGGGCTTTGACAAACTTCCTCTGTGGGGTACCATCCTCATCTCGGTGGGATGTGCAGTT
TTCTGTGCCCTTATCGTCTGGTTCTTTGTATGTCCCAGGATGAAGAGAAAAATTGAACGA
GAAATAAAGTGTAGTCCTTCTGAAAGCCCCTTAATGGAAAAAAAGAATAGCTTGAAAGAA
GACCATGAAGAAACAAAGTTGTCTGTTGGTGATATTGAAAACAAGCATCCTGTTTCTGAG
GTAGGGCCTGCCACTGTGCCCCTCCAGGCTGTGGTGGAGGAGAGAACAGTCTCATTCAAA
CTTGGAGATTTGGAGGAAGCTCCAGAGAGAGAGAGGCTTCCCAGCGTGGACTTGAAAGAG
GAAACCAGCATAGATAGCACCGTGAATGGTGCAGTGCAGTTGCCTAATGGGAACCTTGTC
CAGTTCAGTCAAGCCGTCAGCAACCAAATAAACTCCAGTGGCCACTCCCAGTATCACACC
GTGCATAAGGATTCCGGCCTGTACAAAGAGCTACTCCATAAATTACATCTTGCCAAGGTG
GGAGATTGCATGGGAGACTCCGGTGACAAACCCTTAAGGCGCAATAATAGCTATACTTCC
TATACCATGGCAATATGTGGCATGCCTCTGGATTCATTCCGTGCCAAAGAAGGTGAACAG
AAGGGCGAAGAAATGGAGAAGCTGACATGGCCTAATGCAGACTCCAAGAAGCGAATTCGA
ATGGACAGTTACACCAGTTACTGCAATGCTGTGTCTGACCTTCACTCAGCATCTGAGATA
GACATGAGTGTCAAGGCAGCGATGGGTCTAGGTGACAGAAAAGGAAGTAATGGCTCTCTA
GAAGAATGGTATGACCAGGATAAGCCTGAAGTCTCTCTCCTCTTCCAGTTCCTGCAGATC
CTTACAGCCTGCTTTGGGTCATTCGCCCATGGTGGCAATGACGTAAGCAATGCCATTGGG
CCTCTGGTTGCTTTATATTTGGTTTATGACACAGGAGATGTTTCTTCAAAAGTGGCAACA
CCAATATGGCTTCTACTCTATGGTGGTGTTGGTATCTGTGTTGGTCTGTGGGTTTGGGGA
AGAAGAGTTATCCAGACCATGGGGAAGGATCTGACACCGATCACACCCTCTAGTGGCTTC
AGTATTGAACTGGCATCTGCCCTCACTGTGGTGATTGCATCAAATATTGGCCTTCCCATC
AGTACAACACATTGTAAAGTGGGCTCTGTTGTGTCTGTTGGCTGGCTCCGGTCCAAGAAG
GCTGTTGACTGGCGTCTCTTTCGTAACATTTTTATGGCCTGGTTTGTCACAGTCCCCATT
TCTGGAGTTATCAGTGCTGCCATCATGGCAATCTTCAGATATGTCATCCTCAGAATGTGA
|
| Target 2 GenBank Gene ID |
Not Available |
| Target 2 GeneCard ID |
SLC20A1  |
| Target 2 GenAtlas ID |
SLC20A1  |
| Target 2 HGNC ID |
HGNC:10946  |
| Target 2 Chromosome Location |
Not Available |
| Target 2 Locus |
2q11-q14 |
| Target 2 SNPs |
SNPJam Report  |
| Target 2 Toxin References |
- R207 - Doyle ME, Jan de Beur SM: The skeleton: endocrine regulator of phosphate homeostasis. Curr Osteoporos Rep. 2008 Dec;6(4):134-41. [PubMed
]
|
| Target 2 General References |
2078500; 15815621; 15489334; 9889306; 1309898; 1531369; 8411375; 7929240; 7966619; 8041748 |